共 118 条
[1]
Priori SG(2015)2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC) Europace 17 1601-1687
[2]
Blomström-Lundqvist C(2014)Evolution of left ventricular ejection fraction after acute myocardial infarction: implications for implantable cardioverter-defibrillator eligibility Circulation 130 743-748
[3]
Mazzanti A(2004)Use of a wearable defibrillator in terminating tachyarrhythmias in patients at high risk for sudden death: results of the WEARIT/BIROAD Pacing Clin Electrophysiol 27 4-9
[4]
Sjöblom J(2010)Aggregate national experience with the wearable cardioverter-defibrillator: event rates, compliance, and survival J Am Coll Cardiol 56 194-203
[5]
Muhrbeck J(2013)Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator Eur Heart J 34 2230-2242
[6]
Witt N(2017)The wearable cardioverter-defibrillator: current technology and evolving indications Europace 19 335-345
[7]
Feldman AM(2017)Benefit of the wearable cardioverter-defibrillator in protecting patients after implantable-cardioverter defibrillator explant: results from the National Registry JACC Clin Electrophysiol 3 243-250
[8]
Klein H(2018)Role of the wearable defibrillator in newly diagnosed heart failure Curr Heart Fail Rep 15 368-375
[9]
Tchou P(2015)Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry) Circulation 132 1613-1619
[10]
Chung MK(2013)Wearable cardioverter-defibrillator use in patients perceived to be at high risk early post-myocardial infarction J Am Coll Cardiol 62 2000-2007